Alkermes
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 4 days.
- Recent price momentum is +26.5% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Analyst tilt is Buy.
- Price is below its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-22 08:27 UTC
Data coverage: 5 of 6 factors. Missing data is not a zero score.
The radar needs all six factors. Available grades are shown below.
Valuation N/A
How expensive the stock is versus earnings, sales and its own 5-year history.
Not enough data to grade this factor.
Growth A
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 9.9% | Better than 64% |
| Net income CAGR (3Y) | 224.5% | Better than 99% |
| Free cash flow CAGR (3Y) | 77.4% | Better than 90% |
Profitability A-
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 86.7% | Better than 94% |
| Operating margin | 17.2% | Better than 70% |
| Net margin | 16.4% | Better than 74% |
| Return on equity | 14.7% | Better than 67% |
| Return on invested capital | 12.5% | Better than 77% |
Momentum A-
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | -7.0% | Better than 58% |
| 6-month return | 22.1% | Better than 85% |
| 12-month return (ex latest month) | 52.5% | Better than 84% |
| Distance below 52-week high | 19.3% | Better than 62% |
Financial Health A+
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 3.5x | Better than 78% |
| Debt to assets | 2.8% | Better than 85% |
| Interest coverage | 24.7x | Better than 85% |
| Free cash flow / net income | 198.8% | Better than 77% |
Analyst View B-
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 69.2% | Better than 48% |
| Upside to average target | 37.4% | Better than 57% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 46.18
- Open
- 45.79
- Day range
- 44.83 - 46.89
- Avg price
- 45.43
- Volume
- 1.08M
- Turnover
- 49.10M
- Turnover ratei
- 0.70%
- Volume ratioi
- 0.86
- Amplitudei
- 4.46%
- 52-week rangei
- 27.00 - 55.67
Valuation
- P/Ei
- 31.43
- P/E (TTM)i
- -4,494.00
- P/Bi
- 4.05
- EPSi
- 1.43
- Book value / shi
- 11.10
- Net profit
- 240.30M
- Net assets
- 1.86B
Share structure
- Market cap
- 7.55B
- Float capi
- 6.99B
- Shares out
- 168.04M
- Float sharesi
- 155.48M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 1970-01-01
19.3% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-52.66M net over the window
Short interest
- Shares short
- 19.65M
- % of floati
- 11.71%
- Days to coveri
- 11.25
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Alkermes (ALKS)?
Alkermes last traded at 44.94. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Alkermes's market cap?
About 7.55B.
What is the P/E ratio of Alkermes?
The trailing twelve-month P/E is -4,494.00. The Valuation tab shows it against the stock's own five-year range.
Does Alkermes pay a dividend?
Alkermes does not currently pay a regular dividend.
Is Alkermes a buy according to analysts?
The consensus of 13 analysts is a Buy rating, with an average 12-month price target of 61.73, which implies 37.4% upside from the current price. This is not investment advice.
What is Alkermes's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Alkermes a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.
Quote time 2026-11-20 20:01:09 · For reference only, not investment advice and not tailored to your situation.
Alkermes discussion 0 comments